{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Fièvre chikungunya : Questions médicales les plus fréquentes",
"headline": "Fièvre chikungunya : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Fièvre chikungunya : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-09",
"dateModified": "2025-04-04",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Fièvre chikungunya"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Infections à alphavirus",
"url": "https://questionsmedicales.fr/mesh/D018354",
"about": {
"@type": "MedicalCondition",
"name": "Infections à alphavirus",
"code": {
"@type": "MedicalCode",
"code": "D018354",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C01.925.782.930.100"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Fièvre chikungunya",
"alternateName": "Chikungunya Fever",
"code": {
"@type": "MedicalCode",
"code": "D065632",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Angela Luzia Branco Pinto Duarte",
"url": "https://questionsmedicales.fr/author/Angela%20Luzia%20Branco%20Pinto%20Duarte",
"affiliation": {
"@type": "Organization",
"name": "Departamento de Medicina Clínica, Universidade Federal de Pernambuco, Recife, PE, Brasil."
}
},
{
"@type": "Person",
"name": "Claudia Diniz Lopes Marques",
"url": "https://questionsmedicales.fr/author/Claudia%20Diniz%20Lopes%20Marques",
"affiliation": {
"@type": "Organization",
"name": "Serviço de Reumatologia - Hospital das Clínicas da Universidade Federal de Pernambuco, Núcleo de Pesquisa em Inovação Terapêutica Suely Galdino (Nupit-SG)/ UFPE, Endereço: Av. Prof. Moraes Rego, 1235 - Cidade Universitária, Recife, PE, CEP: 50670-901, Brazil."
}
},
{
"@type": "Person",
"name": "Scott C Weaver",
"url": "https://questionsmedicales.fr/author/Scott%20C%20Weaver",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Nara Gualberto Cavalcanti",
"url": "https://questionsmedicales.fr/author/Nara%20Gualberto%20Cavalcanti",
"affiliation": {
"@type": "Organization",
"name": "Serviço de Reumatologia - Hospital das Clínicas da Universidade Federal de Pernambuco, Núcleo de Pesquisa em Inovação Terapêutica Suely Galdino (Nupit-SG)/ UFPE, Endereço: Av. Prof. Moraes Rego, 1235 - Cidade Universitária, Recife, PE, CEP: 50670-901, Brazil. Electronic address: nara.gual@gmail.com."
}
},
{
"@type": "Person",
"name": "Moacyr Jesus Barreto de Melo Rêgo",
"url": "https://questionsmedicales.fr/author/Moacyr%20Jesus%20Barreto%20de%20Melo%20R%C3%AAgo",
"affiliation": {
"@type": "Organization",
"name": "Serviço de Reumatologia - Hospital das Clínicas da Universidade Federal de Pernambuco, Núcleo de Pesquisa em Inovação Terapêutica Suely Galdino (Nupit-SG)/ UFPE, Endereço: Av. Prof. Moraes Rego, 1235 - Cidade Universitária, Recife, PE, CEP: 50670-901, Brazil."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Single-Cell Transcriptome Analysis Identifies Subclusters with Inflammatory Fibroblast Responses in Localized Scleroderma.",
"datePublished": "2023-06-06",
"url": "https://questionsmedicales.fr/article/37372943",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijms24129796"
}
},
{
"@type": "ScholarlyArticle",
"name": "Kynurenine pathway metabolism evolves with development of preclinical and scleroderma-associated pulmonary arterial hypertension.",
"datePublished": "2023-10-03",
"url": "https://questionsmedicales.fr/article/37786941",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1152/ajplung.00177.2023"
}
},
{
"@type": "ScholarlyArticle",
"name": "Additional value of T1 and T2 mapping techniques for early detection of myocardial involvement in scleroderma.",
"datePublished": "2023-01-31",
"url": "https://questionsmedicales.fr/article/36731634",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ijcard.2023.01.066"
}
},
{
"@type": "ScholarlyArticle",
"name": "Atypical emphysema formation in a never-smoker with scleroderma-related interstitial pneumonia: a case report.",
"datePublished": "2022-08-19",
"url": "https://questionsmedicales.fr/article/36415340",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.11604/pamj.2022.42.295.29442"
}
},
{
"@type": "ScholarlyArticle",
"name": "Validity, Reliability, and Differential Item Functioning of English and French Versions of the 10-Item Connor-Davidson Resilience Scale in Systemic Sclerosis: A Scleroderma Patient-Centered Intervention Network Cohort Study.",
"datePublished": "2023-06-07",
"url": "https://questionsmedicales.fr/article/37128826",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/acr.25139"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Infection",
"item": "https://questionsmedicales.fr/mesh/D007239"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies virales",
"item": "https://questionsmedicales.fr/mesh/D014777"
},
{
"@type": "ListItem",
"position": 4,
"name": "Infections à virus à ARN",
"item": "https://questionsmedicales.fr/mesh/D012327"
},
{
"@type": "ListItem",
"position": 5,
"name": "Infections à Togaviridae",
"item": "https://questionsmedicales.fr/mesh/D014036"
},
{
"@type": "ListItem",
"position": 6,
"name": "Infections à alphavirus",
"item": "https://questionsmedicales.fr/mesh/D018354"
},
{
"@type": "ListItem",
"position": 7,
"name": "Fièvre chikungunya",
"item": "https://questionsmedicales.fr/mesh/D065632"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Fièvre chikungunya - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Fièvre chikungunya",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-08",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Fièvre chikungunya",
"description": "Comment diagnostiquer la fièvre chikungunya ?\nQuels tests sont utilisés pour confirmer l'infection ?\nQuels symptômes indiquent une infection ?\nLa fièvre chikungunya est-elle confondue avec d'autres maladies ?\nQuel est le délai d'apparition des symptômes ?",
"url": "https://questionsmedicales.fr/mesh/D065632?mesh_terms=Scleroderma,+Systemic&page=5#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Fièvre chikungunya",
"description": "Quels sont les symptômes principaux de la fièvre chikungunya ?\nLa douleur articulaire est-elle persistante ?\nY a-t-il des symptômes gastro-intestinaux ?\nLes symptômes varient-ils selon l'âge ?\nPeut-on avoir des symptômes sans fièvre ?",
"url": "https://questionsmedicales.fr/mesh/D065632?mesh_terms=Scleroderma,+Systemic&page=5#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Fièvre chikungunya",
"description": "Comment prévenir la fièvre chikungunya ?\nLes moustiquaires sont-elles efficaces ?\nFaut-il éliminer les eaux stagnantes ?\nLes vaccins existent-ils pour cette maladie ?\nComment se protéger lors de voyages ?",
"url": "https://questionsmedicales.fr/mesh/D065632?mesh_terms=Scleroderma,+Systemic&page=5#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Fièvre chikungunya",
"description": "Quel est le traitement recommandé pour la fièvre chikungunya ?\nLes anti-inflammatoires sont-ils efficaces ?\nFaut-il se reposer pendant la maladie ?\nDes remèdes naturels sont-ils utiles ?\nQuand consulter un médecin ?",
"url": "https://questionsmedicales.fr/mesh/D065632?mesh_terms=Scleroderma,+Systemic&page=5#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Fièvre chikungunya",
"description": "Quelles sont les complications possibles de la fièvre chikungunya ?\nLa fièvre chikungunya peut-elle être mortelle ?\nLes personnes âgées sont-elles plus à risque ?\nY a-t-il des risques de co-infection ?\nComment gérer les douleurs chroniques post-chikungunya ?",
"url": "https://questionsmedicales.fr/mesh/D065632?mesh_terms=Scleroderma,+Systemic&page=5#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Fièvre chikungunya",
"description": "Qui est le plus à risque de contracter la maladie ?\nLes femmes enceintes sont-elles plus vulnérables ?\nLes personnes immunodéprimées sont-elles à risque ?\nLes enfants sont-ils plus touchés ?\nLes voyages dans des zones endémiques augmentent-ils le risque ?",
"url": "https://questionsmedicales.fr/mesh/D065632?mesh_terms=Scleroderma,+Systemic&page=5#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer la fièvre chikungunya ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur les symptômes cliniques et des tests sérologiques ou PCR."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour confirmer l'infection ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests sérologiques détectent les anticorps, tandis que la PCR identifie le virus."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une infection ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, douleurs articulaires, éruptions cutanées et fatigue sont des indicateurs clés."
}
},
{
"@type": "Question",
"name": "La fièvre chikungunya est-elle confondue avec d'autres maladies ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut être confondue avec la dengue ou le virus Zika en raison de symptômes similaires."
}
},
{
"@type": "Question",
"name": "Quel est le délai d'apparition des symptômes ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes apparaissent généralement 4 à 8 jours après la piqûre d'un moustique infecté."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes principaux de la fièvre chikungunya ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fièvre, douleurs articulaires, maux de tête et éruptions cutanées."
}
},
{
"@type": "Question",
"name": "La douleur articulaire est-elle persistante ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la douleur articulaire peut persister plusieurs mois après la guérison initiale."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes gastro-intestinaux ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme des nausées ou des vomissements peuvent survenir, mais sont moins fréquents."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les enfants et les personnes âgées peuvent présenter des symptômes plus sévères et prolongés."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes sans fièvre ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines personnes peuvent éprouver des douleurs articulaires sans fièvre initiale."
}
},
{
"@type": "Question",
"name": "Comment prévenir la fièvre chikungunya ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évitez les piqûres de moustiques en utilisant des répulsifs et en portant des vêtements longs."
}
},
{
"@type": "Question",
"name": "Les moustiquaires sont-elles efficaces ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les moustiquaires traitées avec insecticide protègent contre les piqûres de moustiques."
}
},
{
"@type": "Question",
"name": "Faut-il éliminer les eaux stagnantes ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, éliminer les eaux stagnantes réduit les lieux de reproduction des moustiques."
}
},
{
"@type": "Question",
"name": "Les vaccins existent-ils pour cette maladie ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de vaccin approuvé contre la fièvre chikungunya."
}
},
{
"@type": "Question",
"name": "Comment se protéger lors de voyages ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utilisez des répulsifs, portez des vêtements longs et choisissez des hébergements protégés."
}
},
{
"@type": "Question",
"name": "Quel est le traitement recommandé pour la fièvre chikungunya ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de traitement antiviral spécifique; les soins sont symptomatiques."
}
},
{
"@type": "Question",
"name": "Les anti-inflammatoires sont-ils efficaces ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les anti-inflammatoires non stéroïdiens peuvent soulager la douleur et l'inflammation."
}
},
{
"@type": "Question",
"name": "Faut-il se reposer pendant la maladie ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un repos adéquat est conseillé pour aider à la récupération et réduire la fatigue."
}
},
{
"@type": "Question",
"name": "Des remèdes naturels sont-ils utiles ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains remèdes naturels peuvent aider à soulager les symptômes, mais peu de preuves existent."
}
},
{
"@type": "Question",
"name": "Quand consulter un médecin ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Consultez un médecin si les symptômes s'aggravent ou si des complications apparaissent."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles de la fièvre chikungunya ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des douleurs articulaires chroniques et des problèmes neurologiques."
}
},
{
"@type": "Question",
"name": "La fièvre chikungunya peut-elle être mortelle ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "La fièvre chikungunya n'est généralement pas mortelle, mais des complications peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus à risque ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées peuvent développer des complications plus graves et prolongées."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de co-infection ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la co-infection avec d'autres virus comme la dengue peut compliquer le tableau clinique."
}
},
{
"@type": "Question",
"name": "Comment gérer les douleurs chroniques post-chikungunya ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion inclut des traitements anti-inflammatoires et des thérapies physiques."
}
},
{
"@type": "Question",
"name": "Qui est le plus à risque de contracter la maladie ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes vivant dans des zones endémiques et celles exposées aux moustiques sont à risque."
}
},
{
"@type": "Question",
"name": "Les femmes enceintes sont-elles plus vulnérables ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les femmes enceintes peuvent avoir des complications plus graves et affecter le fœtus."
}
},
{
"@type": "Question",
"name": "Les personnes immunodéprimées sont-elles à risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes immunodéprimées peuvent développer des formes plus sévères de la maladie."
}
},
{
"@type": "Question",
"name": "Les enfants sont-ils plus touchés ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les enfants peuvent contracter la maladie, mais les symptômes sont souvent moins sévères."
}
},
{
"@type": "Question",
"name": "Les voyages dans des zones endémiques augmentent-ils le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, voyager dans des zones où le chikungunya est présent augmente le risque d'infection."
}
}
]
}
]
}
Localized scleroderma (LS) is an autoimmune disease with both inflammatory and fibrotic components causing an abnormal deposition of collagen in the skin and underlying tissue, often leading to disfig...
We evaluated the prevalence of myocardial involvement by native T1 and T2 mapping, the diagnostic performance of mapping in addition to conventional Lake Louise Criteria (LLC), as well as correlations...
Fifty-five SSc patients (52.31 ± 13.24 years, 81.8% female) and 55 age- and sex-matched healthy subjects underwent clinical, bio-humoral assessment, and CMR. The imaging protocol included: T2-weighted...
Global myocardial T1 and T2 values were significantly higher in SSc patients than in healthy subjects. An increase in native T1 and/or T2 was present in the 62.1% of patients with normal conventional ...
T1 and T2 mapping are sensitive parameters that should be included in the routine clinical assessment of SSc patients for detecting early/subclinical myocardial involvement....
Scleroderma is an autoimmune connective tissue disorder which is characterized by fibrosis of visceral organs, blood vessels and skin. The most common manifestations of lung disease in systemic sclero...
Some individuals with systemic sclerosis (SSc) report positive mental health, despite severe disease manifestations, which may be associated with resilience, but no resilience measure has been validat...
Eligible participants were enrolled in the Scleroderma Patient-centered Intervention Network Cohort and completed the CD-RISC-10 between August 2022 and January 2023. We used confirmatory factor analy...
A total of 962 participants were included in this analysis. CFA supported a single-factor structure (Tucker-Lewis index = 0.99, comparative fit index = 0.99, root mean square error of approximation = ...
The CD-RISC-10 is a valid and reliable measure of resilience in SSc, with score comparability across English and French versions....
Scleroderma is an autoimmune disease mainly characterized by progressive fibrosis of the skin. There are two types of scleroderma, namely localized scleroderma (LS) and systemic sclerosis (SSc); skin ...
(1) Background: The UCLA GIT 2.0 questionnaire has been recognized as a feasible and reliable instrument to assess gastrointestinal (GI) symptoms in systemic sclerosis (SSc) patients and their impact ...
The prognosis and therapeutic responses are worse for pulmonary arterial hypertension associated with systemic sclerosis (SSc-PAH) compared with idiopathic pulmonary arterial hypertension (IPAH). This...
Are circulating bioactive metabolites differentially altered in SSc-PAH vs IPAH, and can this alteration explain clinical disparity between these PAH subgroups?...
Plasma biosamples from 400 patients with SSc-PAH and 1,082 patients with IPAH were included in the study. Another cohort of 100 patients with scleroderma with no PH and 44 patients with scleroderma wi...
From hundreds of circulating bioactive lipid molecules, five metabolites were found to distinguish between SSc-PAH and IPAH, as well as associate with markers of disease severity. Relative to IPAH, pa...
Patients with SSc-PAH are characterized by an unfavorable bioactive metabolic profile that may explain the poor and limited response to therapy. These data provide important metabolic insights into th...
Scleroderma is a chronic and progressive autoimmune disorder of connective tissues often causing lesions and deformities of the hands. Individuals affected by this condition experience daily life limi...
Pulmonary hypertension (PH) is a leading cause of death in patients with systemic sclerosis (SSc). An important component of SSc patient management is early detection and treatment of PH. Recently the...
The SEPVADIS trial is a randomized, double-blind, placebo-controlled phase 2 trial of sildenafil in SSc-MEP patients with a target enrollment of 30 patients from two academic sites in the United State...
The SEPVADIS trial will be the first randomized study of sildenafil in SSc-MEP patients. The results of this trial will be used to inform a phase 3 study to investigate the efficacy of treating patien...
ClinicalTrials.gov Identifier NCT04797286....